Literature DB >> 4568563

Preventive treatment of untreated, nonactive tuberculosis in an Eskimo population.

G W Comstock, S F Woolpert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4568563     DOI： 10.1080/00039896.1972.10666182

Source DB:  PubMed          Journal:  Arch Environ Health        ISSN： 0003-9896


× No keyword cloud information.
  7 in total

1.  Clarifying the issues in tuberculosis control.

Authors:  T R Frieden
Journal:  Am J Public Health       Date:  1996-02       Impact factor: 9.308

2.  Tuberculosis control: a special bibliography.

Authors: 
Journal:  Health Serv Rep       Date:  1973 Jun-Jul

3.  A new method for the evaluation of tuberculosis control programs.

Authors:  M L Atkinson
Journal:  Health Serv Rep       Date:  1973 Jun-Jul

4.  Tuberculosis control and social change.

Authors:  T R Frieden
Journal:  Am J Public Health       Date:  1994-11       Impact factor: 9.308

Review 5.  Active case finding of tuberculosis: historical perspective and future prospects.

Authors:  J E Golub; C I Mohan; G W Comstock; R E Chaisson
Journal:  Int J Tuberc Lung Dis       Date:  2005-11       Impact factor: 2.373

6.  Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis.

Authors:  Heui-Dong Park; Kristi M Guinn; Maria I Harrell; Reiling Liao; Martin I Voskuil; Martin Tompa; Gary K Schoolnik; David R Sherman
Journal:  Mol Microbiol       Date:  2003-05       Impact factor: 3.501

7.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.